Go offline with the Player FM app!
United Therapeutics: Leading a Biotech Revolution
Manage episode 438173737 series 2714551
United Therapeutics (Nasdaq: UTHR) is a very smart, very innovative, and very profitable company.
First it treated an untreatable disease. Now it's disrupting the entire organ transplant industry.
In today's show, 7investing CEO Simon Erickson introduces United Therapeutics, describing why the company was created and its five commercially-approved drugs.
He also explains how its four synthetic organ programs could disrupt the entire organ transplant market.
See why United Therapeutics is a stock that should be on your radar. To join our free email list, visit 7investing.com/email.
459 episodes
Manage episode 438173737 series 2714551
United Therapeutics (Nasdaq: UTHR) is a very smart, very innovative, and very profitable company.
First it treated an untreatable disease. Now it's disrupting the entire organ transplant industry.
In today's show, 7investing CEO Simon Erickson introduces United Therapeutics, describing why the company was created and its five commercially-approved drugs.
He also explains how its four synthetic organ programs could disrupt the entire organ transplant market.
See why United Therapeutics is a stock that should be on your radar. To join our free email list, visit 7investing.com/email.
459 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.